Bausch + Lomb Launches Bi-Blade+ Vitrectomy Cutter in the EU on Stellaris Elite Platform

Why It Matters

Higher flow and reduced vibration translate into faster, safer vitrectomies, giving surgeons a competitive edge and potentially improving patient recovery times in a market hungry for advanced ophthalmic tools.

Key Takeaways

• Bi‑Blade+ provides 25% higher vitreous flow than the prior Bi‑Blade
• Cutter vibration is reduced by 62%, boosting surgical stability
• Adaptive Fluidics lowers infusion pressure 62%, supporting IOP stability
• Available EU‑wide on Stellaris Elite for anterior and posterior procedures

Pulse Analysis

Vitrectomy remains a cornerstone of modern ophthalmic surgery, treating conditions from retinal detachments to macular holes. As the global market for vitreoretinal devices expands, manufacturers race to deliver tools that combine speed with precision. Bausch + Lomb, a long‑standing player in ocular health, leverages its Stellaris Elite platform to introduce Bi‑Blade+, a dual‑port cutter that promises to reshape operative workflows. By increasing vitreous removal flow by a quarter, surgeons can complete cases more quickly, reducing operating‑room time and associated costs.

The technical refinements of Bi‑Blade+ go beyond raw speed. A 62% drop in cutter vibration minimizes micro‑trauma to delicate retinal tissue, directly impacting surgical outcomes and surgeon ergonomics. When paired with Adaptive Fluidics, the system also curtails infusion pressure by the same margin, preserving intra‑ocular pressure stability—a critical factor in preventing postoperative complications. These advances collectively enhance procedural safety, potentially lowering the incidence of secondary interventions and improving patient satisfaction.

From a business perspective, the EU launch positions Bausch + Lomb to capture market share from rivals such as Alcon and Zeiss, who are also rolling out next‑generation vitrectomy platforms. Early adoption by high‑volume retinal centers could drive ancillary revenue streams, including consumables and service contracts. Moreover, the technology sets a benchmark for future innovations, prompting competitors to prioritize fluidics control and vibration mitigation. As healthcare providers increasingly value efficiency and outcome data, Bi‑Blade+ is poised to become a reference standard in vitreoretinal surgery.